Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 940-730-5 | CAS number: -
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- From 17th of November, 1980 to 1st of December, 1980
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- No GLP, no guideline claimed but test procedure in accordance with guideline but described in insufficient details (no concentration analysis, no granulometrical analysis, temperature not mentioned ...). Animals were whole-body exposed but cleaned at the end of exposure. Substance analytical certificate not available
- Justification for type of information:
- The justification for read across is provided as an attachment in IUCLID Section 13.
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- From 17th of November, 1980 to 1st of December, 1980
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- No GLP, no guideline claimed but test procedure in accordance with guideline but described in insufficient details (no concentration analysis, no granulometrical analysis, temperature not mentioned ...). Animals were whole-body exposed but cleaned at the end of exposure. Substance analytical certificate not available
- Justification for type of information:
- The justification for read across is provided as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Preliminary study:
- Prior to test exposure, exploratory runs were made with the inhalation equipment to establish dose-setting relation of the test substance and the equipment.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- >= 5.8 mg/L air (nominal)
- Exp. duration:
- 4 h
- Remarks on result:
- other: plus a 29-min equilibration period
- Mortality:
- At the tested dose, no animal died during exposure nor during the 14 days observation period.
- Clinical signs:
- other: see below Table 7.2.2/2
- Body weight:
- See below table 7.2.2/3
- Gross pathology:
- See below table 7.2.2/3
- Other findings:
- No additional data
- Interpretation of results:
- other: Practically non toxic
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the test, C14-C16 n-Paraffins are not classified according to the criteria of Annex VI to the Directive 67/548/EEC and EU GHS.
- Executive summary:
This data is being read across from the source study that tested C14 -C16 n-Paraffins based on analogue read across.
The toxicity of C14-C16 n-Paraffins was tested in COX-SD rats exposed by inhalation. Five males and five females were exposed to the test substance in the form of a mist at a delivery flow concentration of approximately 5.8 mg/L of air at a total flow rate of 9 L/min. The animals were observed for 2 weeks after treatment. At the end of observation period, they were killed and a pathology investigation was performed. No mortality occured during the study. Moderate rales were noted in 2 animals on day 2 to 7, that lasted 9 days or until termination. Moderate thinness was also recorded in 2 animals from day 1 or 2 and lasted 3 to 6 days.
Necropsy showed slight congestion of the lungs in 2 rats and a slight decrease of visceral fatty tissues in one animal.
As the acute LC50 by inhalation was found greater than 5.8 mg/L under the conditions of the test, C14-C16 n-Paraffins are not classified according to the criteria of Annex VI to Directive 67/548/EEC and EU GHS.
Table 7.2.2/2: Toxicological and pharmacological signs at 5.8 mg/L exposure level
Signs |
Number of animals |
Onset |
Degree |
Duration |
Rales |
2/10 |
On day 2 to 7 |
S1- Moderate |
9 days or until termination |
Thinness |
2/10 |
On day 1 to 2 |
S1- Moderate |
3 to 6 days |
Table 7.2.2/3: Necropsy observation of animals sacrificed following the 14-day observation period
Animal no and sex |
Organ |
Findings |
% change in body weight |
1 M |
- |
All organs and tissues grossly not remarkable |
+40.2 |
2 M |
- |
All organs and tissues grossly not remarkable |
+24.4 |
3 M |
- |
All organs and tissues grossly not remarkable |
+38.5 |
4 M |
- |
All organs and tissues grossly not remarkable |
+25.2 |
5 M |
Lungs |
Slight congestion Other organs and tissues grossly not remarkable |
+30.7 |
6 F |
Lungs |
All organs and tissues grossly not remarkable |
+3.1 |
7 F |
- |
All organs and tissues grossly not remarkable |
+3.8 |
8 F |
Fatty tissue (viscera) |
Slight decrease Other organs and tissues grossly not remarkable |
+1.9 |
9 F |
- |
All organs and tissues grossly not remarkable |
+5.7 |
10 F |
- |
All organs and tissues grossly not remarkable |
+10.5 |
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- Animals were whole-body exposed but cleaned at the end of exposure; no chamber concentration analysis, no granulometrical analysis
- Principles of method if other than guideline:
- Guideline principles
- GLP compliance:
- no
- Remarks:
- Not specified
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- C14-C16 n-Paraffins
- IUPAC Name:
- C14-C16 n-Paraffins
- Details on test material:
- - Name of test material (as cited in study report): C14-C16 n-Paraffins
- Substance type: Petroleum product, UVCB
- Analytical purity: 100% commercial product
- Composition of test material, percentage of components: C14-C16 n-paraffins
- Lot/batch No.: 8728K
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: COX-SD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No additional data
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: DeVilbiss Nebulizer at delivery flow of 5.8 mg mist/L air
- Exposure chamber volume: 57 L
- Method of holding animals in test chamber: individually housed in metal, wire-bottomed cages elevated above the droppings.
- Source and rate of air: 9 L/min for 4-hour exposure period
- Method of conditioning air: no data
- System of generating particulates/aerosols: DeVilbiss Nebulizer
- Method of particle size determination: no data
- Treatment of exhaust air: no data
- Temperature, humidity, pressure in air chamber: no data
TEST ATMOSPHERE: no data
VEHICLE: no vehicle - Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- 4 h
- Remarks on duration:
- plus a 29-min equilibration period
- Concentrations:
- 5.8 mg/L air
- No. of animals per sex per dose:
- 5 rats/sex/dose (see Table 7.2.2/1)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: at regular intervals during the first days and once daily thereafter for fourteen days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, after sacrifice: body weight,organ weights, organ examination, histopathology - Statistics:
- No data
Results and discussion
- Preliminary study:
- Prior to test exposure, exploratory runs were made with the inhalation equipment to establish dose-setting relation of the test substance and the equipment.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- >= 5.8 mg/L air (nominal)
- Exp. duration:
- 4 h
- Remarks on result:
- other: plus a 29-min equilibration period
- Mortality:
- At the tested dose, no animal died during exposure nor during the 14 days observation period.
- Clinical signs:
- other: see below Table 7.2.2/2
- Body weight:
- See below table 7.2.2/3
- Gross pathology:
- See below table 7.2.2/3
- Other findings:
- No additional data
Any other information on results incl. tables
Table 7.2.2/2: Toxicological and pharmacological signs at 5.8 mg/L exposure level
Signs |
Number of animals |
Onset |
Degree |
Duration |
Rales |
2/10 |
On day 2 to 7 |
S1- Moderate |
9 days or until termination |
Thinness |
2/10 |
On day 1 to 2 |
S1- Moderate |
3 to 6 days |
Table 7.2.2/3: Necropsy observation of animals sacrificed following the 14-day observation period
Animal no and sex |
Organ |
Findings |
% change in body weight |
1 M |
- |
All organs and tissues grossly not remarkable |
+40.2 |
2 M |
- |
All organs and tissues grossly not remarkable |
+24.4 |
3 M |
- |
All organs and tissues grossly not remarkable |
+38.5 |
4 M |
- |
All organs and tissues grossly not remarkable |
+25.2 |
5 M |
Lungs |
Slight congestion Other organs and tissues grossly not remarkable |
+30.7 |
6 F |
Lungs |
All organs and tissues grossly not remarkable |
+3.1 |
7 F |
- |
All organs and tissues grossly not remarkable |
+3.8 |
8 F |
Fatty tissue (viscera) |
Slight decrease Other organs and tissues grossly not remarkable |
+1.9 |
9 F |
- |
All organs and tissues grossly not remarkable |
+5.7 |
10 F |
- |
All organs and tissues grossly not remarkable |
+10.5 |
Applicant's summary and conclusion
- Interpretation of results:
- other: Practically non toxic
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the test, C14-C16 n-Paraffins are not classified according to the criteria of Annex VI to the Directive 67/548/EEC and EU GHS.
- Executive summary:
The toxicity of C14-C16 n-Paraffins was tested in COX-SD rats exposed by inhalation. Five males and five females were exposed to the test substance in the form of a mist at a delivery flow concentration of approximately 5.8 mg/L of air at a total flow rate of 9 L/min. The animals were observed for 2 weeks after treatment. At the end of observation period, they were killed and a pathology investigation was performed. No mortality occured during the study. Moderate rales were noted in 2 animals on day 2 to 7, that lasted 9 days or until termination. Moderate thinness was also recorded in 2 animals from day 1 or 2 and lasted 3 to 6 days.
Necropsy showed slight congestion of the lungs in 2 rats and a slight decrease of visceral fatty tissues in one animal.
As the acute LC50 by inhalation was found greater than 5.8 mg/L under the conditions of the test, C14-C16 n-Paraffins are not classified according to the criteria of Annex VI to Directive 67/548/EEC and EU GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
